Affinity Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $833K | Buy |
13,730
+198
| +1% | +$11.5K | 0.52% | 66 |
|
|
2025
Q4 | $730K | Sell |
13,532
-130
| -1% | -$6.25K | 0.48% | 71 |
|
|
2025
Q3 | $616K | Sell |
13,662
-360
| -3% | -$16.8K | 0.42% | 76 |
|
|
2025
Q2 | $649K | Sell |
14,022
-470
| -3% | -$23.1K | 0.49% | 73 |
|
|
2025
Q1 | $884K | Sell |
14,492
-132
| -0.9% | -$7.69K | 0.72% | 49 |
|
|
2024
Q4 | $827K | Sell |
14,624
-3,568
| -20% | -$199K | 0.69% | 55 |
|
|
2024
Q3 | $941K | Buy |
18,192
+117
| +0.6% | +$5.49K | 0.65% | 56 |
|
|
2024
Q2 | $751K | Sell |
18,075
-148
| -0.8% | -$6.62K | 0.56% | 64 |
|
|
2024
Q1 | $988K | Sell |
18,223
-42
| -0.2% | -$2.14K | 0.72% | 51 |
|
|
2023
Q4 | $937K | Sell |
18,265
-2,140
| -10% | -$112K | 0.64% | 51 |
|
|
2023
Q3 | $1.18M | Sell |
20,405
-583
| -3% | -$35.7K | 0.76% | 39 |
|
|
2023
Q2 | $1.34M | Sell |
20,988
-4,934
| -19% | -$331K | 0.78% | 41 |
|
|
2023
Q1 | $1.8M | Sell |
25,922
-16,594
| -39% | -$1.17M | 0.96% | 23 |
|
|
2022
Q4 | $3.06M | Hold |
42,516
| – | – | 1.41% | 12 |
|
|
2022
Q3 | $3.02M | Sell |
42,516
-554
| -1% | -$40.2K | 1.57% | 9 |
|
|
2022
Q2 | $3.32M | Sell |
43,070
-446
| -1% | -$34K | 1.62% | 10 |
|
|
2022
Q1 | $3.18M | Sell |
43,516
-302
| -0.7% | -$20.3K | 1.3% | 11 |
|
|
2021
Q4 | $2.73M | Sell |
43,818
-4,090
| -9% | -$240K | 1.1% | 27 |
|
|
2021
Q3 | $2.83M | Sell |
47,908
-349
| -0.7% | -$23K | 1.27% | 19 |
|
|
2021
Q2 | $3.23M | Sell |
48,257
-18,910
| -28% | -$1.23M | 1.46% | 12 |
|
|
2021
Q1 | $4.24M | Sell |
67,167
-1,600
| -2% | -$99.5K | 1.55% | 17 |
|
|
2020
Q4 | $4.27M | Sell |
68,767
-2,811
| -4% | -$173K | 1.72% | 12 |
|
|
2020
Q3 | $4.32M | Buy |
71,578
+3,739
| +6% | +$225K | 1.89% | 12 |
|
|
2020
Q2 | $3.99M | Sell |
67,839
-9,016
| -12% | -$539K | 1.9% | 11 |
|
|
2020
Q1 | $4.28M | Sell |
76,855
-1,672
| -2% | -$102K | 2.18% | 11 |
|
|
2019
Q4 | $5.04M | Sell |
78,527
-14,376
| -15% | -$823K | 1.83% | 13 |
|
|
2019
Q3 | $4.71M | Sell |
92,903
-3,344
| -3% | -$157K | 1.48% | 28 |
|
|
2019
Q2 | $4.37M | Sell |
96,247
-60,110
| -38% | -$2.8M | 1.25% | 38 |
|
|
2019
Q1 | $7.46M | Sell |
156,357
-43,027
| -22% | -$2.14M | 1.53% | 28 |
|
|
2018
Q4 | $10.4M | Sell |
199,384
-17,750
| -8% | -$954K | 1.81% | 18 |
|
|
2018
Q3 | $13.5M | Buy |
+217,134
| New | +$12.9M | 1.78% | 18 |
|
|
2016
Q3 | – | Sell |
-4,492
| Closed | -$330K | – | 154 |
|
|
2016
Q2 | $330K | Hold |
4,492
| – | – | 0.02% | 128 |
|
|
2016
Q1 | $287K | Buy |
+4,492
| New | +$283K | 0.03% | 130 |
|
Other funds holding BMY
VCM
VPM
Affinity Investment Advisors's BMY Position: Q1 2026 in Review
Affinity Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 1.5% in Q1 2026, buying an estimated $11.5K and bringing the position to 13,730 shares worth $833K. The position accounts for 0.52% of the portfolio, ranked #66.
Affinity Investment Advisors first reported a position in BMY in Q1 2016 and has held it in 33 quarters since. The position peaked at $13.5M in Q3 2018. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Affinity Investment Advisors held 13,730 shares of Bristol-Myers Squibb worth $833K as of Q1 2026.
- Affinity Investment Advisors bought 198 Bristol-Myers Squibb shares in Q1 2026, an estimated $11.5K.
- Bristol-Myers Squibb made up 0.52% of Affinity Investment Advisors's portfolio in Q1 2026, its #66 holding.
- Affinity Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 33 quarters since.
- Affinity Investment Advisors's Bristol-Myers Squibb position peaked at $13.5M in Q3 2018.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Affinity Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.